Tabel 1.
PTSD patients (n = 10)
|
Comparison subjects (n = 10)
|
Time × diagnosis int.-F | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baseline
|
Neutral-1
|
Neutral-2
|
Combat-1
|
Combat-2
|
Baseline
|
Neutral-1
|
Neutral-2
|
Combat-1
|
Combat-2
|
||||||||||||
Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | ||
Systolic BP | 130.9 | 9.5 | 135.4 | 17.1 | 130.2 | 9.1 | 133.5 | 7.3 | 137.1 | 11.8 | 128.5 | 12.1 | 133.1 | 16.2 | 131.4 | 16.3 | 129.0 | 11.5 | 131.3 | 14.1 | 0.2 |
Diastolic BP | 78.8 | 5.6 | 80.3 | 7.4 | 80.6 | 6.3 | 84.6 | 8.0 | 86.0 | 6.8 | 77.5 | 5.1 | 79.0 | 4.9 | 80.3 | 6.0 | 80.1 | 6.8 | 79.2 | 7.9 | 0.86a |
Pulse | 69.0 | 15.6 | 68.6 | 13.2 | 65.4 | 12.0 | 66.3 | 11.3 | 66.6 | 12.0 | 67.9 | 11.8 | 67.1 | 10.0 | 66.0 | 10.0 | 65.2 | 8.1 | 66.2 | 9.3 | 0.0 |
CADSS | 1.9 | 2.6 | 3.6 | 4.3 | 7.5 | 7.7 | 7.1 | 8.8 | 12.3 | 12.1 | 1.8 | 4.1 | 3.9 | 6.6 | 1.4 | 2.8 | 1.9 | 3.2 | 1.0 | 1.9 | 2.94a,b |
PASS | 28.8 | 2.1 | 29.4 | 2.2 | 32.7 | 5.9 | 35.5 | 8.3 | 41.8 | 13.7 | 27.4 | 1.0 | 28.6 | 3.4 | 27.4 | 0.7 | 27.2 | 0.6 | 27.6 | 1.6 | 4.78b,c |
PTSD Scale | 15.3 | 1.1 | 16.5 | 2.5 | 19.5 | 7.3 | 25.5 | 6.5 | 32.5 | 7.7 | 14.0 | 0.0 | 14.1 | 0.3 | 14.1 | 0.3 | 14.5 | 1.3 | 14.2 | 0.6 | 15.1 |
Fear analogue | 0.05 | 0.11 | 0.05 | 0.10 | 0.03 | 0.08 | 0.15 | 0.17 | 0.26 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | 4.33 |
SUDs | 13.0 | 12.0 | 11.0 | 11.0 | 15.0 | 17.0 | 33.0 | 16.0 | 42.0 | 28.0 | 1.0 | 3.0 | 4.0 | 13.0 | 3.0 | 8.0 | 3.0 | 8.0 | 0.0 | 0.0 | 5.58 |
CADSS, Clinician Administered Dissociative States Scale; PASS, Panic Attack Symptom Scale; SUDs, Subjective Units of Distress scale.
Significant main effect for diagnosis (p < .05).
Significant time by diagnosis interaction (p < .05).
Duncan’s multiple range test showed significant increase during combat slides relative to neutral slides and baseline in the PTSD patients (p < .05).